Company Directory / research

PrivateFor profitresearchLondon, United Kingdom
We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins.
Size
11-50 people: larger than 33% of companies with a size listed
Age
8 years old.
Reach
Website ranked #8,542,615 in the world for traffic, about 515 visits a month.
BiotechnologyPharmaceutical
Funding, as listed
$42M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Peptone, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
Peptone may be growing as indicated by the context within the news articles. The global peptone market is experiencing an expansion, particularly in emerging markets in the Asia-Pacific region, which suggests a growing demand for products like those offered by Peptone. Additionally, Peptone is highlighted in an article discussing the company's approach to finding opportunities in disorder, which could imply innovation and potential market advantage. Furthermore, the mention of major players in the global peptone market analysis report, which includes a period from 2023 to 2028, indicates a competitive but potentially growing market environment for Peptone.
Summaries written by the source dataset, not by us, and not checked.
research in United Kingdom.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 372,993 companies in United Kingdom and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.